Baseline TK1 expression levels and corresponding patient survival data were systematically extracted for meta-analysis.<h4>Results</h4>The meta-analysis evaluating the association between baseline TK1 expression levels and progression-free survival (PFS) in breast cancer included 2,887 patients from 11 studies. This evidence concerns the gene TK1 and breast cancer.